Management of Chronic Lymphocytic Leukaemia

被引：0
作者：
Tse, E. [1 ]
Gill, H. Singh [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Haematol & Oncol & Bone Marrow Transplantat, Pokfulam, Hong Kong, Peoples R China
来源：
HONG KONG JOURNAL OF RADIOLOGY | 2011年 / 14卷 / 04期
关键词：
Combined Modality Therapy; Leukemia; lymphoid; Lymph nodes; Rituximab;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Chronic lymphocytic leukaemia is a disease that primarily affects the elderly and has a heterogeneous clinical course. The past decade has witnessed extensive progress in its management, owing to the generation of prognostic biological markers that influence therapeutic decisions, as well as the development of novel therapeutic agents that improve the treatment response and survival. This review discusses the value of various prognostic markers in the management of chronic lymphocytic leukaemia and the treatment options with conventional chemotherapy and newer chemoimmunotherapy regimens. However, treatment needs to be tailored to individual patients according to the patient's general physical state, ability to tolerate treatment-related toxicity, and presence of comorbidities. To that end, an approach to formulating primary and secondary treatment decisions is also presented.
引用
收藏
页码：S56 / S62
页数：7
相关论文
共 47 条
  • [1] Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
    Badoux, Xavier C.
    Keating, Michael J.
    Wang, Xuemei
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Faderl, Stefan
    Burger, Jan
    Koller, Charles
    Lerner, Susan
    Kantarjian, Hagop
    Wierda, William G.
    [J]. BLOOD, 2011, 117 (11) : 3016 - 3024
  • [2] BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
  • [3] 2-V
  • [4] Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia
    Bosch, Francesc
    Abrisqueta, Pau
    Villamor, Neus
    Jose Terol, Maria
    Gonzalez-Barca, Eva
    Ferra, Christelle
    Gonzalez Diaz, Marcos
    Abella, Eugenia
    Delgado, Julio
    Carbonell, Felix
    Garcia Marco, Jose Antonio
    Escoda, Lourdes
    Ferrer, Secundino
    Monzo, Encarnacion
    Gonzalez, Yolanda
    Estany, Cristina
    Jarque, Isidro
    Salamero, Olga
    Muntanola, Ana
    Montserrat, Emili
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4578 - 4584
  • [5] Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
    Catovsky, D.
    Richards, S.
    Matutes, E.
    Oscier, D.
    Dyer, M. J. S.
    FBezares, R.
    Pettitt, A. R.
    Hamblin, T.
    Milligan, D. W.
    Child, J. A.
    Hamilton, M. S.
    Dearden, C. E.
    Smith, A. G.
    Bosanquet, A. G.
    Davis, Z.
    Brito-Babapulle, V.
    Else, M.
    Wade, R.
    Hillmen, P.
    [J]. LANCET, 2007, 370 (9583) : 230 - 239
  • [6] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [7] ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
    Crespo, M
    Bosch, F
    Villamor, N
    Bellosillo, B
    Colomer, D
    Rozman, M
    Marcé, S
    López-Guillermo, A
    Campo, E
    Montserrat, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) : 1764 - 1775
  • [8] Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
    Damle, RN
    Wasil, T
    Fais, F
    Ghiotto, F
    Valetto, A
    Allen, SL
    Buchbinder, A
    Budman, D
    Dittmar, K
    Kolitz, J
    Lichtman, SM
    Schulman, P
    Vinciguerra, VP
    Rai, KR
    Ferrarini, M
    Chiorazzi, N
    [J]. BLOOD, 1999, 94 (06) : 1840 - 1847
  • [9] Chlorambucil in indolent chronic lymphocytic leukemia
    Dighiero, G
    Maloum, K
    Desablens, B
    Cazin, B
    Navarro, M
    Leblay, R
    Leporrier, M
    Jaubert, J
    Lepeu, G
    Dreyfus, B
    Binet, JL
    Travade, P
    Turpin, FL
    Tertian, G
    Bichoffe, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) : 1506 - 1514
  • [10] Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner, H
    Stilgenbauer, S
    Benner, A
    Leupolt, E
    Kröber, A
    Bullinger, L
    Döhner, K
    Bentz, M
    Lichter, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) : 1910 - 1916
12345